Skip to main content
OpenTrials
Recruiting

NCT Number: NCT02526095

The French EsoGastricTumours Data Base

This retrospective study aims at evaluating the outcomes of gastrointestinal stromal tumor after surgery.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Esophageal Disease Digestive System Diseases Esophageal Diseases Gastrointestinal Diseases

Age range

18 year–90 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Chu Amiens Picardie, Amiens, France

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patient with

  • esophageal cancer, gastric or gastroesophageal junction diagnosed biopsy , regardless of the subtype of cancer, tumor stage or treatment envisaged.
  • Naive treatment for this cancer,
  • Naive treatment for this cancer , failing that received neoadjuvant treatment ,
  • Male or female ≥ 18 years.
  • social protection scheme .
  • sign a free and informed consent for blood sampling , the different questionnaires and the collection of patient information.

Exclusion criteria

Male or female aged ( e) under 18 years.

  • Private person of liberty or under supervision (including guardianship ) .
  • People who do not speak French.
  • Major Nobody unable to consent .
  • Patient FREGAT already included in the base.
  • Patient Refusal .

Treatment and study plan

Primary outcomes

  1. DIsease free survival

    Time frame: 5 year disease free survival

Secondary outcomes

  1. overall survival

    Time frame: 5 year overall survival

  2. recurrence rate

    Time frame: 5 year recurrence rate

  3. Total number of patients with complications

    Time frame: from the time between inclusion and occurrence of the event, for the duration of 3 years

  4. Total number of complications

    Time frame: from the time between inclusion and occurrence of the event, for the duration of 3 years

  5. Death

    Time frame: from the time between inclusion and occurrence of the event, for the duration of 3 years

Study contacts

Contact information is provided by the study sponsor or research team.

Guillaume Piessen, MD, PhD

CONTACT

[email protected]

+3320444407

Sponsors and collaborators

Lead sponsor

University Hospital, Lille

Other

Collaborators

  • French Eso-Gastric Tumors Working Group
  • National Cancer Institute, France

Registry information

Official study title

National Oesophageal and Gastric Carcinomas Data Base Construction: the FREGAT (French EsoGastric Tumours) Data Base

Acronym: FREGAT

Important dates

Study start
2014
Primary completion
2027
Study completion
2027
First posted
Aug 18, 2015
Registry last updated
May 14, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.